Drug delivery at the aortic valve tissues of healthy domestic pigs with a paclitaxel-eluting valvuloplasty balloon

Journal of Interventional Cardiology

Volumn 22, Issue 3, 2009, Pages 291-298

  Spargias, Konstantinos ^a,e   Milewski, Krzystof ^b   Debinski, Marcin ^b   Buszman, Piotr P ^b   Cokkinos, Dennis V ^a   Pogge, Rembert ^c   Buszman, Pawel ^b,d  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b American Heart of Poland   (Poland)

^c Eurocor GmbH   (Germany)

^d MEDICAL UNIVERSITY OF SILESIA   (Poland)

^e NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; ANTINEOPLASTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTIC VALVE REPAIR; ARTICLE; CONTROLLED STUDY; DOMESTIC PIG; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; MEMBRANE LEAFLET; NONHUMAN; PRIORITY JOURNAL; TRANSLUMINAL VALVULOPLASTY; ANIMAL; AORTA VALVE; CATHETERIZATION; DRUG EFFECTS; FEASIBILITY STUDY; PATHOLOGY; SURGERY; SWINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AORTIC VALVE; CATHETERIZATION; DRUG DELIVERY SYSTEMS; DRUG-ELUTING STENTS; FEASIBILITY STUDIES; PACLITAXEL; SWINE;

EID: 66749144633     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2009.00447.x     Document Type: Article

References (49)

1. Task Force. ACC-AHA 2006 guidelines for the management of patients with valvular heart disease. Circulation 2006 114 : 84 231.
2. The task force on the management of valvular heart disease of the European Society of Cardiology. Guidelines on the management of valvular heart disease. Eur Heart J 2007 28 : 230 268.
3. Hara H, Pedersen WR, Ladich E, et al. Percutaneous balloon aortic valvuloplasty revisited: Time for a renaissance? Circulation 2007 115 : 334 338.
4. Kolh P, Kerzmann A, Lahaye L, et al. Cardiac surgery in octogenarians. Peri-operative outcome and long-term results. Eur Heart J 2001 22 : 1235 1243. (Pubitemid 32702960)
5. Varadarajan P, Kapoor N, Bansal RC, et al. Survival in elderly patients with severe aortic stenosis is dramatically improved by aortic valve replacement: Results from a cohort of 277 patients aged ≥80 years. Eur J Cardiothorac Surg 2006 30 : 722 727. (Pubitemid 44574533)
6. Edwards MB, Taylor KM. Outcomes in nonagenarians after heart valve replacement operation. Ann Thorac Surg 2003 75 : 830 834. (Pubitemid 36298351)
7. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro heart survey on valvular heart disease. Eur Heart J 2003 24 : 1231 1243. (Pubitemid 36834640)
8. Charlson E, Legedza AT, Hamel MB. Decision-making and outcomes in severe symptomatic aortic stenosis. J Heart Valve Dis 2006 15 : 312 321.
9. Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005 111 : 3290 3295. (Pubitemid 40875002)
10. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007 116 : 755 763. (Pubitemid 47255993)
11. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: Device success and 30-day clinical outcome. J Am Coll Cardiol 2007 50 : 69 76. (Pubitemid 46970878)
12. Webb JG, Pasupati S, Achtem L, et al. Rapid pacing to facilitate transcatheter prosthetic heart valve implantation. Catheter Cardiovasc Interv 2006 68 : 199 204. (Pubitemid 44167668)
13. Klein A, Lee K, Gera A, et al. Long-term mortality, cause of death, and temporal trends in complications after percutaneous aortic balloon valvuloplasty for calcific aortic stenosis. J Interv Cardiol 2006 19 : 269 275. (Pubitemid 43823316)
14. Shareghi S, Rasouli L, Shavelle DM, et al. Current results of balloon aortic valvuloplasty in high-risk patients. J Invasive Cardiol 2007 19 : 1 5. (Pubitemid 46088063)
15. Pedersen WR, Klaassen PJ, Boisjolie CR, et al. Feasibility of transcatheter intervention for severe aortic stenosis in patients ≥90 years of age: Aortic valvuloplasty revisited. Catheter Cardiovasc Interv 2007 70 : 149 154.
16. Lieberman EB, Bashore TM, Hermiller JB, et al. Balloon aortic valvuloplasty in adults: Failure of procedure to improve long-term survival. J Am Coll Cardiol 1995 26 : 1522 1528.
17. Agarwal A, Kini A, Attanti S, et al. Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years. Am J Cardiol 2005 95 : 43 47. (Pubitemid 40051110)
18. Feldman T, Glagov S, Carroll JD. Restenosis following successful balloon valvuloplasty: Bone formation in aortic valve leaflets. Cathet Cardiovasc Diagn 1993 29 : 1 7. (Pubitemid 23145557)
19. Van Den Brand M, Essed CE, DiMario C, et al. Histological changes in the aortic valve after balloon dilatation: Evidence for a delayed healing process. Br Heart J 1992 67 : 445 449.
20. Waller BF, Dorros G, Lewin RF, et al. Catheter balloon valvuloplasty of stenotic aortic valves. Part II: Balloon valvuloplasty during life subsequent tissue examination. Clin Cardiol 1991 14 : 924 930.
21. Serruys PW, Luijten HE, Beatt KJ, et al. Percutaneous balloon valvuloplasty for calcific aortic stenosis. A treatment 'sine cure'? Eur Heart J 1988 9 : 782 794. (Pubitemid 18190118)
22. Safian RD, Mandell VS, Thurer RF, et al. Postmortem and intraoperative valvuloplasty of calcific aortic stenosis in elderly patients: Mechanisms of successful dilatation. J Am Coll Cardiol 1987 9 : 655 660. (Pubitemid 17024590)
23. McKay RG, Safian RD, Lock JE, et al. Balloon dilatation of calcific aortic stenosis in elderly patients: Postmortem, intraoperative, and percutaneous valvuloplasty studies. Circulation 1986 74 : 119 125. (Pubitemid 16092932)
24. Dorros G, Lewin RF, Stertzer SH, et al. Percutaneous transluminal aortic valvuloplasty: The acute outcome and follow-up of 149 patients who underwent the double balloon technique. Eur Heart J 1990 11 : 429 440. (Pubitemid 20174907)
25. NHLBI Balloon Valvuloplasty Registry Participants. Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results from the NHLBI balloon valvuloplasty registry. Circulation 1991 84 : 2383 2397.
26. McKay RG, Safian RD, Lock JE, et al. Assessment of left ventricular and aortic valve function after aortic balloon valvuloplasty in adult patients with critical aortic stenosis. Circulation 1987 75 : 192 203. (Pubitemid 17234558)
27. Harrison JK, Davidson CJ, Leithe ME, et al. Serial left ventricular performance evaluated by cardiac catheterization before, immediately after and at 6 months after balloon aortic valvuloplasty. J Am Coll Cardiol 1990 16 : 1351 1358.
28. Otto CM, Mickel MC, Kennedy JW, et al. Three-year outcome after balloon aortic valvuloplasty: Insights into prognosis of valvular aortic stenosis. Circulation 1994 89 : 642 650. (Pubitemid 24056191)
29. Nishimura RA, Holmes DR Jr., Reeder GS, et al. Hemodynamic results of percutaneous aortic balloon valvuloplasty as assessed by sequential Doppler echocardiographic studies. Int J Cardiol 1988 20 : 317 326. (Pubitemid 18195084)
30. Harpole DH, Davidson CJ, Skelton TN, et al. Early and late changes in left ventricular systolic performance after percutaneous aortic balloon valvuloplasty. Am J Cardiol 1990 66 : 327 332. (Pubitemid 20235758)
31. Davidson CJ, Harpole DA, Kisslo K, et al. Analysis of the early rise in aortic transvalvular gradient after aortic valvuloplasty. Am Heart J 1989 117 : 411 417. (Pubitemid 19059792)
32. Bossé Y, Mathieu P, Pibarot P. Genomics: The next step to elucidate the etiology of calcific aortic valve stenosis. J Am Coll Cardiol 2008 51 1327 1336.
33. Otto CM, Kuusisto J, Reichenbach DD, et al. Characterization of the early lesion of 'degenerative' valvular aortic stenosis histological and immunohistochemical studies. Circulation 1994 90 : 844 853. (Pubitemid 24242754)
34. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease. Pathogenesis, disease progression, and treatment strategies. Circulation 2005 111 : 3316 3326. (Pubitemid 40875006)
35. Helske S, Kupari M, Lindstedt KA, et al. Aortic stenosis: An active atheroinflammatory process. Curr Opin Lipidiol 2007 18 : 483 491. (Pubitemid 47462199)
36. Mohler ER, Adam LP, McClelland P, et al. Detection of Osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol 1997 17 : 547 552. (Pubitemid 27133146)
37. Helske S, Lindstedt KA, Laine M, et al. Induction of local angiotensin II-producing systems in stenosed aortic valve. J Am Coll Cardiol 2004 44 : 1859 1866. (Pubitemid 39424087)
38. Rajamannan NM, Subramaniam M, Rickard D, et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003 107 : 2181 2184. (Pubitemid 36547209)
39. Pedersen WR, Van Tassel RA, Pierce TA, et al. Radiation following percutaneous balloon valvuloplasty to prevent restenosis (RADAR pilot trial). Catheter Cardiovasc Interv 2006 68 : 183 192. (Pubitemid 44167666)
40. Ong AT, Serruys PW. Technology Insight: An overview of research in drug-eluting stents. Nat Clin Pract Cardiovasc Med 2005 2 : 647 658. (Pubitemid 43012602)
41. Herdeg C, Oberhoff M, Baumbach A, et al. Local paclitaxel delivery for the prevention of restenosis: Biological effects and efficacy in vivo. J Am Coll Cardiol 2000 35 : 1969 1976. (Pubitemid 30342882)
42. Sheikh SH, Mulchandani A. Continuous-flow fluoro-immunosensor for paclitaxel measurement. Biosens Bioelectron 2001 16 : 647 652. (Pubitemid 33000193)
43. Giannakakou P, Robey R, Fojo T, et al. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1-G2 arrest instead of mitotic arrest: Molecular determinants of paclitaxel-induced cytotoxicity. Oncogene 2001 20 : 3806 3813. (Pubitemid 32646191)
44. Blagosklonny MV, Darzynkiewicz Z, Halicka HD, et al. Paclitaxel induces primary and postmitotic G1 arrest in human arterial smooth muscle cells. Cell Cycle 2004 3 : 1050 1056. (Pubitemid 40268664)
45. Axel DI, Kunert W, Göggelmann C, et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 1997 96 : 636 645. (Pubitemid 27329445)
46. Mullins DW, Koci MD, Burger CJ, et al. Interleukin-12 overcomes paclitaxel-mediated suppression of T-cell proliferation. Immunopharmacol Immunotoxicol 1998 20 : 473 492. (Pubitemid 28491709)
47. Posa A, Hemetsberger R, Petnehazy O, et al. Attainment of local drug delivery with paclitaxel-eluting balloon in porcine coronary arteries. Coron Artery Dis 2008 19 : 243 247.
48. Heldman AW, Cheng L, Jenkins JM, et al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation 2001 103 : 2289 2295. (Pubitemid 32433720)
49. Scheller B, Hehrlein C, Bocksch W, et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006 355 : 2113 2124. (Pubitemid 44749319)